Category: Abbott LaboratoriesSyndicate content

Abbott inks co-distribution deal with Carl Zeiss Meditec

October 17, 2014 by Brad Perriello

Abbott says it inked a non-exclusive deal to sell Carl Zeiss Meditec's cataract surgery products alongside its own eye surgery offerings and announces FDA clearance for a pair of laser cataract surgery devices.

Abbott inks co-distribution deal with Carl Zeiss Meditec

Mazzo suspended at Versant Ventures after insider trading indictment | Personnel Moves

October 15, 2014 by Brad Perriello

James Mazzo and Versant Ventures agree to suspend Mazzo after his indictment on insider trading charges stemming from Abbott's $2.8 billion acquisition of Advanced Medical Optics.

Mazzo suspended at Versant Ventures after insider trading indictment | Personnel Moves

Versant Ventures and James Mazzo agreed that Mazzo will "suspend any activities" at the venture capital shop following his indictment last month on insider trading charges.

Medtronic shareholder sues over company's plan to cover nearly $58M in taxes | Medtech legal news for the week of October 13, 2014

October 13, 2014 by MassDevice

Here's a look at some of the top legal news stories for medical device companies this week: Shareholder sues Medtronic over plan to cover execs' $58m tax tab; Report: Bard's mesh settlement is worth $21m; Covidien's Ev3 logs a pair of legal wins over Appriva, whistleblower; BD loses bid to overturn $114m antitrust loss to Retractable Technologies; Ex-Oriole DeCinces fights insider trading charges

Shareholder sues Medtronic over plan to cover execs' $58m tax tab

October 7, 2014 by Brad Perriello

Feds fight dismissal of charges in Abbott-AMO insider trading case

October 10, 2014 by Brad Perriello

Federal prosecutors fight a move by ex-Orioles baseballer Doug DeCinces to have charges dropped from the insider trading case involving ex-Advanced Medical Optics CEO James Mazzo, who's accused of passing along inside info on Abbott's $2.8 billion AMO buyout.

Feds fight dismissal of charges in Abbott-AMO insider trading case

Federal prosecutors are fighting a bid by Doug DeCinces, the ex-Orioles player accused of insider trading on information he got from former Advanced Medical Optics CEO James Mazzo, to have a raft of charges dropped from his indictment.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Ex-Oriole DeCinces fights insider trading charges

October 8, 2014 by Brad Perriello

Ex-Orioles baseballer Doug DeCinces, accused of insider trading around Abbott's Advanced Medical Optics acquisition, wants 19 charges dropped from his indictment.

Ex-Oriole DeCinces fights insider trading charges

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Abbott Vascular to shutter Texas plant, move 50 jobs to California

September 23, 2014 by Alex Soule

Abbott Vascular plans to shutter a plant in Texas that makes its Supera peripheral stents as it shifts production and 50 jobs to another plant in California.

Abbott Vascular to shutter Texas plant, move 50 jobs to California

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

India considers price cap on medical devices

September 22, 2014 by Brian Johnson

India mulls instituting a maximum retail price cap on medical devices in the wake of price gouging allegations against some of medtech's largest players.

YYmeta

Indian regulators may impose price control measures on such medical devices as stents, catheters and implants in response to allegations of price gouging and bribery, according to a report in the Business Standard.

India's health ministry and department of pharamaceuticals are considering a maximum retail price cap under the National Pharmaceutical Pricing Authority, which monitors the price of 348 medicines deemed essential, the Indian newspaper reported.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp